Summary

The global amniotic products market is projected to reach USD 1.0 billion by 2026 from USD 0.7 billion in 2021, at a CAGR of 8.2% during the forecast period. The growth in this market can be attributed to the growth in the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management, rising venture capital investments and government funding, increasing number of traumatic wounds, growing number of amniotic membrane transplantations, and the increasing number of ophthalmology, cosmetic, and orthopedic surgeries. The amniotic products market is segmented based on type, application, end user, and region.

“Amniotic membrane segment is expected to dominate the market during the forecast period.”

Based on type, the amniotic products market is segmented into amniotic membranes and amniotic suspensions. Amniotic membrane account for the largest share of the amniotic products market. The large share of this segment can be attributed to to its increased use in a number of procedures. Moreover, amniotic membranes are more effective than amniotic suspensions.


“Wound care segment to dominate the market during the forecast period.”

Based on application, the amniotic products market is segmented into wound care, ophthalmology, orthopedics, and other applications. The wound care applications segment commanded the largest share of the amniotic products market. The large share of this segment can be attributed to the growing incidence of ulcers, traumatic and surgical wounds, and burns and the need for advanced technologies for treatment.


“Hospitals& Ambulatory Surgery Centers segment to dominate the market during the forecast period.”

Based on end user, the amniotic products market is segmented into hospitals & ambulatory surgery centers (ASCs) and other end users (research institutes and laboratories). Hospitals, and ASCs for the largest share of the amniotic products market. The large share is attributed to the rising incidence of hospital-acquired pressure ulcers, the increasing number of severe burn cases and rising awareness about advanced burn care treatment, and the availability of reimbursement.

“North America will dominate the market during the forecast period.”

The global amniotic products market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, and the Rest of Asia Pacific), Latin America and Middle East & Africa. In 2020, North America dominated the global amniotic products market, followed by Europe. The large share of the North American market can be attributed to the high prevalence of target diseases, increasing geriatric population, rising awareness about advanced treatment options, and the strong presence of key market players in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type -Tier 1: 48%,Tier 2: 34% and Tier 3: 18%
• By Designation - C-level:33%, D-level:40%, and Others:27%
• By Region - North America:36%, Europe:28%, Asia Pacific:19%, Latin America: 10%, and Middle East & Africa: 7%

List of Companies Profiled in the Report
• MiMedx (US)
• Smith & Nephew (UK)
• Organogenesis Inc. (US)
• Integra LifeSciences (US)
• Stryker (US)
• Applied Biologics (US)
• Celularity, Inc. (US)
• Katena Products, Inc. (US)
• Lucina BioSciences (US)
• Next Biosciences (South Africa)
• Skye Biologics Holdings, LLC (US)
• Surgenex (US)
• TissueTech, Inc. (US)
• Ventris Medical, LLC (US)
• StimLabs LLC (US)
• VIVEX Biologics, Inc. (US)
• LifeCell International Pvt. Ltd. (India)
• NuVision Biotherapies Ltd. (UK)
• Genesis Biologics (US)
• Surgilogix (US)
• Tides Medical (US)
• Orthofix Medical Inc. (US)
• AlloSource (US)
• Merakris Therapeutics (US)
• MTF Biologics (US)

Research Coverage:
This report provides a detailed picture of the global amniotic productsmarket. It aims at estimating the size and future growth potential of the market across different segments, such astype, application, end userand region. The report also analyzes factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total amniotic products market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on amniotic products offered by the top 25 players in the amniotic products market. The report analyses the amniotic products market by product, application, end user and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various amniotic products across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the amniotic products market.

Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the amniotic products market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 28
1.3 MARKET SCOPE 28
FIGURE 1 AMNIOTIC PRODUCTS MARKET SEGMENTATION 28
1.3.1 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 29
1.5 STAKEHOLDERS 29
1.6 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 2 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Secondary sources 33
2.1.2 PRIMARY DATA 34
2.1.2.1 Primary sources 34
2.1.2.2 Key data from primary sources 35
2.1.2.3 Key industry insights 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 36
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 37
2.2.1 GROWTH FORECAST 38
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 6 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 7 DATA TRIANGULATION METHODOLOGY 40
2.4 MARKET SHARE ANALYSIS 40
2.5 ASSUMPTIONS FOR THE STUDY 41
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS 41
2.6 LIMITATIONS 42
2.7 RISK ASSESSMENT 42
2.8 GROWTH RATE ASSUMPTIONS 42
2.9 COVID-19 ECONOMIC ASSESSMENT 43
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 43
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 43
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 44
3 EXECUTIVE SUMMARY 45
FIGURE 10 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 45
FIGURE 11 AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 46
FIGURE 12 AMNIOTIC PRODUCTS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 46
FIGURE 13 AMNIOTIC PRODUCTS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 47
4 PREMIUM INSIGHTS 48
4.1 AMNIOTIC PRODUCTS MARKET OVERVIEW 48
FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH 48
4.2 AMNIOTIC PRODUCTS MARKET, BY TYPE (2021–2026) 49
FIGURE 15 AMNIOTIC MEMBRANES SEGMENT TO REGISTER THE HIGHEST CAGR
DURING THE FORECAST PERIOD 49
4.3 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE AND COUNTRY (2020) 49
FIGURE 16 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN AMNIOTIC PRODUCTS MARKET IN 2020 49
4.4 AMNIOTIC PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
FIGURE 17 US AND UK TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
FIGURE 18 AMNIOTIC PRODUCTS MARKET: DRIVERS, OPPORTUNITIES,
AND CHALLENGES 51
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 52
5.2.1.1 Growth in the target patient population 52
TABLE 1 GLOBAL PREVALENCE OF DIABETES 52
5.2.1.2 Rising incidence of burn injuries 53
5.2.1.3 Awareness programs for wound care treatment and management 54
TABLE 2 WOUND CARE AWARENESS INITIATIVES 54
5.2.1.4 Rising venture capital investments and government funding 54
TABLE 3 FUNDING FOR REGENERATIVE MEDICINE RESEARCH BY THE NIH
UNDER THE 21ST CENTURY CURES ACT 55
FIGURE 19 ARTICLES RELATED TO AMNIOTIC PRODUCTS PUBLISHED
FROM 2010 TO 2020 55
5.2.1.5 Increasing number of traumatic wounds 56
5.2.1.6 Growing number of amniotic membrane transplantations 56
TABLE 4 NO. OF AMNIOTIC MEMBRANE TRANSPLANTATIONS PERFORMED IN UNIVERSITY EYE HOSPITAL TÜBINGEN, GERMANY 56
5.2.1.7 Increasing number of ophthalmology, cosmetic,
and orthopedic surgeries 56
5.2.2 OPPORTUNITIES 57
5.2.2.1 Emerging economies 57
TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC 58
5.2.2.2 Implementation of the 21st Century Cures Act (US) 58
5.2.2.3 Increasing demand for stem cell research and regenerative medicine 58
FIGURE 20 STEM CELL RESEARCH FUNDING IN THE LAST 10 YEARS 58
TABLE 6 NIH FUNDING FOR CELL-BASED RESEARCH, 2016–2021 (USD MILLION) 59
5.2.3 CHALLENGES 60
5.2.3.1 Complications and limitations associated with the use of
amniotic membranes 60
5.3 RANGES/SCENARIOS 60
5.3.1 AMNIOTIC PRODUCTS MARKET 60
FIGURE 21 PESSIMISTIC SCENARIO 60
FIGURE 22 OPTIMISTIC SCENARIO 61
FIGURE 23 REALISTIC SCENARIO 61
5.4 COVID-19 IMPACT ON THE AMNIOTIC PRODUCTS MARKET 62
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 63
5.5.1 REVENUE SHIFT & REVENUE POCKETS FOR AMNIOTIC
PRODUCT MANUFACTURERS 63
5.5.2 REVENUE SHIFT FOR THE AMNIOTIC PRODUCTS MARKET 64
5.6 PRICING ANALYSIS 64
TABLE 7 PRICES OF AMNIOTIC PRODUCTS 64
5.7 SUPPLY CHAIN ANALYSIS 65
FIGURE 24 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES 65
5.8 VALUE CHAIN ANALYSIS 66
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING
THE DEVELOPMENT PHASE 66
5.9 ECOSYSTEM ANALYSIS 67
5.9.1 ROLE IN THE ECOSYSTEM 67
TABLE 8 ROLE OF KEY PLAYERS IN THE ECOSYSTEM 67
FIGURE 26 KEY PLAYERS IN THE AMNIOTIC PRODUCTS ECOSYSTEM 68
5.10 TECHNOLOGY ANALYSIS 68
5.11 PATENT ANALYSIS 69
5.12 TRADE ANALYSIS 69
TABLE 9 IMPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF
THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY,
2016-2020 (USD MILLION) 69
TABLE 10 EXPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF
THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY,
2016-2020 (USD MILLION) 70
5.13 REGULATORY LANDSCAPE 70
5.13.1 NORTH AMERICA 70
5.13.2 EUROPE 70
5.13.3 EMERGING COUNTRIES 71

5.14 PORTER’S FIVE FORCES ANALYSIS 71
TABLE 11 PORTER’S FIVE FORCES ANALYSIS 71
5.14.1 INTENSITY OF COMPETITIVE RIVALRY 72
5.14.2 BARGAINING POWER OF SUPPLIERS 72
5.14.3 BARGAINING POWER OF BUYERS 72
5.14.4 THREAT OF SUBSTITUTES 72
5.14.5 THREAT OF NEW ENTRANTS 72
6 AMNIOTIC PRODUCTS MARKET, BY TYPE 73
6.1 INTRODUCTION 74
6.2 PRIMARY NOTES 74
TABLE 12 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 74
TABLE 13 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 74
6.3 AMNIOTIC MEMBRANES 75
TABLE 14 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION) 75
TABLE 15 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION) 75
TABLE 16 AMNIOTIC MEMBRANES MARKET, BY REGION, 2017–2019 (USD MILLION) 75
TABLE 17 AMNIOTIC MEMBRANES MARKET, BY REGION, 2020–2026 (USD MILLION) 76
6.3.1 CRYOPRESERVED AMNIOTIC MEMBRANES 76
6.3.1.1 Cryopreserved amniotic membranes will dominate the
amniotic membranes market during the forecast period 76
TABLE 18 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION,
2017–2019 (USD MILLION) 77
TABLE 19 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION,
2020–2026 (USD MILLION) 77
6.3.2 DEHYDRATED AMNIOTIC MEMBRANES 77
6.3.2.1 Logistical advantages of dehydrated amniotic membranes over cryopreserved amniotic membranes to drive market growth 77
TABLE 20 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION,
2017–2019 (USD MILLION) 78
TABLE 21 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION,
2020–2026 (USD MILLION) 78
6.4 AMNIOTIC SUSPENSIONS 79
6.4.1 ANTI-INFLAMMATORY AND ANTIMICROBIAL PROPERTIES OF
AMNIOTIC SUSPENSIONS TO DRIVE MARKET GROWTH 79
TABLE 22 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2017–2019 (USD MILLION) 79
TABLE 23 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2020–2026 (USD MILLION) 80
7 AMNIOTIC PRODUCTS MARKET, BY APPLICATION 81
7.1 INTRODUCTION 82
7.2 PRIMARY NOTES 82
TABLE 24 AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 82
TABLE 25 AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 83
7.3 WOUND CARE 83
7.3.1 WOUND CARE IS THE LARGEST APPLICATION SEGMENT OF
THE AMNIOTIC PRODUCTS MARKET 83
TABLE 26 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION,
2017–2019 (USD MILLION) 84
TABLE 27 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION,
2020–2026 (USD MILLION) 84
7.4 ORTHOPEDICS 85
7.4.1 BENEFITS OFFERED BY AMNIOTIC PRODUCTS FOR ORTHOPEDIC APPLICATIONS TO DRIVE MARKET GROWTH 85
TABLE 28 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION,
2017–2019 (USD MILLION) 85
TABLE 29 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION,
2020–2026 (USD MILLION) 86
7.5 OPHTHALMOLOGY 86
7.5.1 LIGHTWEIGHT, THIN, AND ELASTIC NATURE OF AMNIOTIC MEMBRANES MAKES THEM SUITABLE FOR USE IN OPHTHALMOLOGY 86
TABLE 30 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION,
2017–2019 (USD MILLION) 87
TABLE 31 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION,
2020–2026 (USD MILLION) 87
7.6 OTHER APPLICATIONS 87
TABLE 32 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2019 (USD MILLION) 88
TABLE 33 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2026 (USD MILLION) 88
8 AMNIOTIC PRODUCTS MARKET, BY END USER 89
8.1 INTRODUCTION 90
TABLE 34 AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION) 90
TABLE 35 AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION) 90
8.2 HOSPITALS & AMBULATORY SURGERY CENTERS 90
8.2.1 HOSPITALS & ASCS FORM THE LARGEST END-USER SEGMENT OF
THE AMNIOTIC PRODUCTS MARKET 90
TABLE 36 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED
IN THE US 92
TABLE 37 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION,
2017–2019 (USD MILLION) 92
TABLE 38 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION,
2020–2026 (USD MILLION) 93
8.3 OTHER END USERS 93
TABLE 39 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION,
2017–2019 (USD MILLION) 94
TABLE 40 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION,
2020–2026 (USD MILLION) 94

9 AMNIOTIC PRODUCTS MARKET, BY REGION 95
9.1 INTRODUCTION 96
TABLE 41 AMNIOTIC PRODUCTS MARKET, BY REGION, 2017–2019 (USD MILLION) 96
TABLE 42 AMNIOTIC PRODUCTS MARKET, BY REGION, 2020–2026 (USD MILLION) 96
9.2 NORTH AMERICA 97
FIGURE 27 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET SNAPSHOT 97
TABLE 43 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 98
TABLE 44 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 98
TABLE 45 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 98
TABLE 46 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 99
TABLE 47 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 99
TABLE 48 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 99
TABLE 49 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 100
TABLE 50 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 100
TABLE 51 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 100
TABLE 52 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 101
9.2.1 US 101
9.2.1.1 The US dominates the North American amniotic products market 101
TABLE 53 US: KEY MACROINDICATORS 102
TABLE 54 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 102
TABLE 55 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 102
TABLE 56 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION) 103
TABLE 57 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION) 103
TABLE 58 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 103
TABLE 59 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 104
TABLE 60 US: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 104
TABLE 61 US: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 104
9.2.2 CANADA 105
9.2.2.1 Rising prevalence of target diseases to drive market growth 105
TABLE 62 CANADA: KEY MACROINDICATORS 105
TABLE 63 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 105
TABLE 64 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 106
TABLE 65 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 106
TABLE 66 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 106
TABLE 67 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 107
TABLE 68 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 107
TABLE 69 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 107
TABLE 70 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 108
9.3 EUROPE 108
TABLE 71 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 108
TABLE 72 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 109
TABLE 73 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 109
TABLE 74 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 109
TABLE 75 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 110
TABLE 76 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 110
TABLE 77 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 110
TABLE 78 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 111
TABLE 79 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 111
TABLE 80 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 111
9.3.1 UK 112
9.3.1.1 The UK accounted for the largest share of the European amniotic products market in 2020 112
TABLE 81 UK: KEY MACROINDICATORS 112
TABLE 82 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 113
TABLE 83 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 113
TABLE 84 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION) 113
TABLE 85 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION) 113
TABLE 86 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 114
TABLE 87 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 114
TABLE 88 UK: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 114
TABLE 89 UK: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 115
9.3.2 GERMANY 115
9.3.2.1 Increasing incidence of diabetes to drive market growth in Germany 115
TABLE 90 GERMANY: KEY MACROINDICATORS 116
TABLE 91 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 116
TABLE 92 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 116
TABLE 93 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 117
TABLE 94 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 117
TABLE 95 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 117
TABLE 96 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 118
TABLE 97 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 118
TABLE 98 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 118
9.3.3 FRANCE 119
9.3.3.1 Rising government support to drive the demand for amniotic products in France 119
TABLE 99 FRANCE: KEY MACROINDICATORS 119
TABLE 100 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 119
TABLE 101 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 120
TABLE 102 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 120
TABLE 103 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 120
TABLE 104 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 121
TABLE 105 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 121
TABLE 106 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 121
TABLE 107 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 122
9.3.4 REST OF EUROPE 122
TABLE 108 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 123
TABLE 109 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 123
TABLE 110 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 123
TABLE 111 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017–2019 (USD MILLION) 124
TABLE 112 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020–2026 (USD MILLION) 124
TABLE 113 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 124
TABLE 114 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 125
TABLE 115 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 125
TABLE 116 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 125
9.4 ASIA PACIFIC 126
FIGURE 28 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET SNAPSHOT 126
TABLE 117 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 127
TABLE 118 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 127
TABLE 119 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 127
TABLE 120 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 128
TABLE 121 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 128
TABLE 122 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 128
TABLE 123 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 129
TABLE 124 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 129
TABLE 125 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 129
TABLE 126 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 130
9.4.1 CHINA 130
9.4.1.1 China to dominate the Asia Pacific amniotic products market
during the forecast period 130
TABLE 127 CHINA: KEY MACROINDICATORS 131
TABLE 128 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 131
TABLE 129 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 131
TABLE 130 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 132
TABLE 131 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 132
TABLE 132 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 132
TABLE 133 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 133
TABLE 134 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 133
TABLE 135 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 133
9.4.2 JAPAN 134
9.4.2.1 Growing geriatric population to drive market growth in Japan 134
TABLE 136 JAPAN: KEY MACROINDICATORS 134
TABLE 137 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017–2019 (USD MILLION) 135
TABLE 138 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 135
TABLE 139 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 135
TABLE 140 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 135
TABLE 141 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 136
TABLE 142 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 136
TABLE 143 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 136
TABLE 144 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 137
9.4.3 REST OF ASIA PACIFIC 137
TABLE 145 ROAPAC: DIABETES PREVALENCE (% OF POPULATION AGED 20–79),
BY COUNTRY, 2019 137
TABLE 146 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 138
TABLE 147 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 138
TABLE 148 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 138
TABLE 149 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 138
TABLE 150 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 139
TABLE 151 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 139
TABLE 152 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 139
TABLE 153 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 140
9.5 LATIN AMERICA 140
9.5.1 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH 140
TABLE 154 LATIN AMERICA: DIABETES PREVALENCE (% OF POPULATION AGED 20–79), BY COUNTRY, 2019 140
TABLE 155 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 141
TABLE 156 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 141
TABLE 157 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 141
TABLE 158 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 141
TABLE 159 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 142
TABLE 160 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 142
TABLE 161 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2017–2019 (USD MILLION) 142
TABLE 162 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER,
2020–2026 (USD MILLION) 143
9.6 MIDDLE EAST & AFRICA 143
9.6.1 SIGNIFICANT GROWTH IN HEALTHCARE INFRASTRUCTURE AND GOVERNMENT INITIATIVES TO FAVOR MARKET GROWTH 143
TABLE 163 MIDDLE EAST & AFRICA: DIABETES PREVALENCE (% OF POPULATION
AGED 20–79), BY COUNTRY, 2019 144
TABLE 164 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2017–2019 (USD MILLION) 144
TABLE 165 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE,
2020–2026 (USD MILLION) 144
TABLE 166 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2017–2019 (USD MILLION) 145
TABLE 167 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE,
2020–2026 (USD MILLION) 145
TABLE 168 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 145
TABLE 169 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 146
TABLE 170 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017–2019 (USD MILLION) 146
TABLE 171 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020–2026 (USD MILLION) 146
10 COMPETITIVE LANDSCAPE 147
10.1 OVERVIEW 147
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 147
TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY AMNIOTIC
PRODUCT MARKET PLAYERS 147
10.3 REVENUE SHARE ANALYSIS 148
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE AMNIOTIC PRODUCTS MARKET 148
10.4 MARKET SHARE ANALYSIS 149
FIGURE 30 AMNIOTIC PRODUCTS MARKET SHARE ANALYSIS, 2020 149
TABLE 173 AMNIOTIC PRODUCTS MARKET: DEGREE OF COMPETITION (2020) 149
10.5 COMPANY EVALUATION QUADRANT 151
10.5.1 STARS 151
10.5.2 EMERGING LEADERS 151
10.5.3 PERVASIVE PLAYERS 151
10.5.4 PARTICIPANTS 151
FIGURE 31 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT (2020) 152
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS 153
10.6.1 PROGRESSIVE COMPANIES 153
10.6.2 STARTING BLOCKS 153
10.6.3 RESPONSIVE COMPANIES 153
10.6.4 DYNAMIC COMPANIES 153
FIGURE 32 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020) 154
10.7 COMPETITIVE SCENARIO 155
10.7.1 DEALS 155
TABLE 174 DEALS 155
10.7.2 PRODUCT LAUNCHES & APPROVALS 156
TABLE 175 PRODUCT LAUNCHES & APPROVALS 156
10.7.3 OTHER DEVELOPMENTS 157
TABLE 176 OTHER DEVELOPMENTS 157
10.8 COMPANY FOOTPRINT ANALYSIS 158
TABLE 177 COMPANY FOOTPRINT ANALYSIS 158
TABLE 178 COMPANY PRODUCT FOOTPRINT 159
TABLE 179 COMPANY REGIONAL FOOTPRINT 160
11 COMPANY PROFILES 161
11.1 KEY PLAYERS 161
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 MIMEDX 161
TABLE 180 MIMEDX: BUSINESS OVERVIEW 161
FIGURE 33 MIMEDX: COMPANY SNAPSHOT (2020) 161
11.1.2 SMITH & NEPHEW PLC 164
TABLE 181 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 164
FIGURE 34 SMITH & NEPHEW: COMPANY SNAPSHOT (2020) 165
11.1.3 ORGANOGENESIS INC. 167
TABLE 182 ORGANOGENESIS INC.: BUSINESS OVERVIEW 167
FIGURE 35 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020) 167
11.1.4 INTEGRA LIFESCIENCES 170
TABLE 183 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW 170
FIGURE 36 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020) 171
11.1.5 STRYKER 173
TABLE 184 STRYKER: BUSINESS OVERVIEW 173
FIGURE 37 STRYKER: COMPANY SNAPSHOT (2020) 174
11.1.6 APPLIED BIOLOGICS 176
TABLE 185 APPLIED BIOLOGICS: BUSINESS OVERVIEW 176
11.1.7 CELULARITY INC. 177
TABLE 186 CELULARITY INC.: BUSINESS OVERVIEW 177
11.1.8 KATENA PRODUCTS, INC. 178
TABLE 187 KATENA PRODUCTS, INC.: BUSINESS OVERVIEW 178
11.1.9 LUCINA BIOSCIENCES 180
TABLE 188 LUCINA BIOSCIENCES: BUSINESS OVERVIEW 180
11.1.10 NEXT BIOSCIENCES 181
TABLE 189 NEXT BIOSCIENCES: BUSINESS OVERVIEW 181
11.1.11 SKYE BIOLOGICS HOLDINGS, LLC 182
TABLE 190 SKYE BIOLOGICS HOLDINGS, LLC: BUSINESS OVERVIEW 182
11.1.12 SURGENEX 183
TABLE 191 SURGENEX: BUSINESS OVERVIEW 183
11.2 OTHER PLAYERS 184
11.2.1 TISSUETECH, INC. 184
11.2.2 VENTRIS MEDICAL, LLC 186
11.2.3 STIMLABS LLC 187
11.2.4 VIVEX BIOLOGICS 188
11.2.5 LIFECELL INTERNATIONAL PVT. LTD. 189
11.2.6 NUVISION BIOTHERAPIES LTD 190
11.2.7 GENESIS BIOLOGICS 191
11.2.8 SURGILOGIX 192
11.2.9 TIDES MEDICAL 193
11.2.10 ORTHOFIX MEDICAL INC. 194
11.2.11 ALLOSOURCE 195
11.2.12 MERAKRIS THERAPEUTICS 196
11.2.13 MTF BIOLOGICS 197
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX 198
12.1 INSIGHTS FROM INDUSTRY EXPERTS 198
12.2 DISCUSSION GUIDE 198
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 202
12.4 AVAILABLE CUSTOMIZATIONS 204
12.5 RELATED REPORTS 204
12.6 AUTHOR DETAILS 205